Human Molecular Genetics, 2000, Vol. 9, No. 17 2479-2489
© 2000 Oxford University Press
The neuronal apoptosis inhibitory protein suppresses neuronal differentiation and apoptosis in PC12 cells
Klinische Forschergruppe Neuroregeneration, Department of Neurology a/nd 1Institute für Medizinische Strahlenkunde und Zellforschung, University of Würzburg, Versbacher Strasse 5, D-97080 Würzburg, Germany
The human neuronal apoptosis inhibitory protein (NAIP) gene has been discovered as a candidate gene for spinal muscular atrophy, a genetic disorder characterized by motor neuron loss in the spinal cord. The telomeric NAIP gene on human chromosome 5 is deleted together with survival motor neurons (SMN) in many cases of the most severe forms of the disorder. NAIP, c-IAP1 (inhibitor of apoptosis-1), c-IAP2, X-IAP, survivin and Apollon comprise the mammalian inhibitors of the apoptosis family and contain an N-terminal domain with 1–3 imperfect repeats of an 
65 amino acids domain named the baculovirus IAP repeat (BIR) motif. We identified six NAIP genes in the mouse genome which were found to be expressed in a broad range of tissues. Furthermore, we have investigated the effects of NAIP in the rat pheochromocytoma PC12 cell line. These cells differentiate in the presence of nerve growth factor (NGF) into cells that resemble sympathetic neurons. We observed that NAIP overexpression impaired NGF-induced neurite outgrowth. The BIR motifs of NAIP (residues 1–345) were not required for this effect. However, the BIR domains of NAIP were essential to prevent apoptosis in PC12 cells after NGF deprivation or TNF-
receptor stimulation. Expression of full-length but not BIR-deleted-NAIP protects against cell death. This correlates with reduced activity of the cell death effector protease, caspase-3, in lysates of NAIP-PC12 cells, as measured by cleavage of the fluorogenic tetrapeptide substrate Asp-Glu-Val-Asp. Thus, unregulation of cellular differentiation and/or caspase suppression may contribute to motoneuron dysfunction and cell death in spinal muscular atrophy where NAIP is mutated.
+ To whom correspondence should be addressed. Tel: +49 931 201 3849; Fax: +49 931 201 3835; Email: goetz@mail.uni-wuerzburg.de
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. I. Ferreira, J. F. Garcia, J. Suela, M. Mollejo, F. I. Camacho, A. Carro, S. Montes, M. A. Piris, and J. C. Cigudosa Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia Haematologica, May 1, 2008; 93(5): 670 - 679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K.X. Maier, S. Balabanian, C. R. Coffill, A. Stewart, L. Pelletier, D. J. Franks, N. H. Gendron, and A. E. MacKenzie Distribution of Neuronal Apoptosis Inhibitory Protein in Human Tissues J. Histochem. Cytochem., September 1, 2007; 55(9): 911 - 923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Fernando and L. A. Megeney Is caspase-dependent apoptosis only cell differentiation taken to the extreme? FASEB J, January 1, 2007; 21(1): 8 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dziarmaga, P.-A. Hueber, D. Iglesias, N. Hache, A. Jeffs, N. Gendron, A. MacKenzie, M. Eccles, and P. Goodyer Neuronal apoptosis inhibitory protein is expressed in developing kidney and is regulated by PAX2 Am J Physiol Renal Physiol, October 1, 2006; 291(4): F913 - F920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. F. Moore, H. Li, N. Jeffries, V. Wright, R. A. Cooper Jr, A. Elkahloun, M. P. Gelderman, E. Zudaire, G. Blevins, H. Yu, et al. Using Peripheral Blood Mononuclear Cells to Determine a Gene Expression Profile of Acute Ischemic Stroke: A Pilot Investigation Circulation, January 18, 2005; 111(2): 212 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Plenchette, S. Cathelin, C. Rebe, S. Launay, S. Ladoire, O. Sordet, T. Ponnelle, N. Debili, T.-H. Phan, R.-A. Padua, et al. Translocation of the inhibitor of apoptosis protein c-IAP1 from the nucleus to the Golgi in hematopoietic cells undergoing differentiation: a nuclear export signal-mediated event Blood, October 1, 2004; 104(7): 2035 - 2043. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Harada, K.-i. Seino, H. Wakao, S. Sakata, Y. Ishizuka, T. Ito, S. Kojo, T. Nakayama, and M. Taniguchi Down-regulation of the invariant V{alpha}14 antigen receptor in NKT cells upon activation Int. Immunol., February 1, 2004; 16(2): 241 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. G. Sanna, J. d. S. Correia, O. Ducrey, J. Lee, K. Nomoto, N. Schrantz, Q. L. Deveraux, and R. J. Ulevitch IAP Suppression of Apoptosis Involves Distinct Mechanisms: the TAK1/JNK1 Signaling Cascade and Caspase Inhibition Mol. Cell. Biol., March 15, 2002; 22(6): 1754 - 1766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. W. M. Jordan, D. Dinev, V. LeMellay, J. Troppmair, R. Gotz, L. Wixler, M. Sendtner, S. Ludwig, and U. R. Rapp Neurotrophin Receptor-interacting Mage Homologue Is an Inducible Inhibitor of Apoptosis Protein-interacting Protein That Augments Cell Death J. Biol. Chem., October 19, 2001; 276(43): 39985 - 39989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Schweizer, J. Gunnersen, C. Karch, S. Wiese, B. Holtmann, K. Takeda, S. Akira, and M. Sendtner Conditional gene ablation of Stat3 reveals differential signaling requirements for survival of motoneurons during development and after nerve injury in the adult J. Cell Biol., January 21, 2002; 156(2): 287 - 298. [Abstract] [Full Text] [PDF]
|
|